{"count": 35, "results": [{"_id": "37529015", "pmid": 37529015, "pmcid": "PMC10390098", "title": "Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells", "journal": "Dev Reprod", "authors": ["Park D", "Lee S", "Boo H"], "date": "2023-06-01T00:00:00Z", "doi": "10.12717/DR.2023.27.2.77", "meta_date_publication": "2023 Jun", "meta_volume": "27", "meta_issue": "2", "meta_pages": "77-89", "score": 50259.758, "text_hl": "@GENE_MAPK14 @GENE_81649 @@@p38MAPK@@@ participates in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@fat accumulation@@@ and apoptosis", "citations": {"NLM": "Park D, Lee S, Boo H. Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells Dev Reprod. 2023 Jun;27(2):77-89. PMID: 37529015", "BibTeX": "@article{37529015, title={Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells}, author={Park D and Lee S and Boo H}, journal={Dev Reprod}, volume={27}, number={2}, pages={77-89}}"}}, {"_id": "33599105", "pmid": 33599105, "pmcid": "PMC8251758", "title": "Combination of bis (alpha-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Combination of bis (alpha -furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through downregulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Liu Q", "Li L", "Gao L", "Li C", "Huan Y", "Lei L", "Cao H", "Li L", "Gao A", "Liu S", "Shen Z"], "date": "2021-06-01T00:00:00Z", "doi": "10.1111/bcpt.13573", "meta_date_publication": "2021 Jun", "meta_volume": "128", "meta_issue": "6", "meta_pages": "747-757", "score": 50259.6, "text_hl": "BFOV + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ significantly decreased serum @GENE_GPT @GENE_76282 @@@ALT@@@ and @GENE_SLC17A5 @GENE_235504 @@@AST@@@ activities and reduced hepatic @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglyceride@@@ content and @GENE_NOS2 @GENE_18126 @@@iNOS@@@ activities, accompanied by ameliorating intrahepatic @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@fat accumulation@@@ and hepatocellular vacuolation. ", "citations": {"NLM": "Liu Q, Li L, Gao L, Li C, Huan Y, Lei L, Cao H, Li L, Gao A, Liu S, Shen Z. Combination of bis (alpha-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Combination of bis (alpha -furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through downregulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Basic Clin Pharmacol Toxicol. 2021 Jun;128(6):747-757. PMID: 33599105", "BibTeX": "@article{33599105, title={Combination of bis (alpha-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Combination of bis (alpha -furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through downregulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice}, author={Liu Q and Li L and Gao L and Li C and Huan Y and Lei L and Cao H and Li L and Gao A and Liu S and Shen Z}, journal={Basic Clin Pharmacol Toxicol}, volume={128}, number={6}, pages={747-757}}"}}, {"_id": "39845516", "pmid": 39845516, "title": "Fatty Acid Synthase (FASN) Inhibitors Suppress Metformin-Induced Fat Accumulation and Apoptosis in H4IIE Hepatocellular Carcinoma Cells.", "journal": "Dev Reprod", "authors": ["Park D", "Boo H"], "date": "2024-12-01T00:00:00Z", "doi": "10.12717/DR.2024.28.4.163", "meta_date_publication": "2024 Dec", "meta_volume": "28", "meta_issue": "4", "meta_pages": "163-174", "score": 50256.48, "text_hl": "@GENE_FASN @GENE_50671 @@@Fatty Acid Synthase@@@ (@GENE_FASN @GENE_50671 @@@FASN@@@) Inhibitors Suppress @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Induced @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@Fat Accumulation@@@ and Apoptosis in @CELLLINE_CVCL:0284 @@@H4IIE@@@ @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@Hepatocellular Carcinoma@@@ Cells.", "citations": {"NLM": "Park D, Boo H. Fatty Acid Synthase (FASN) Inhibitors Suppress Metformin-Induced Fat Accumulation and Apoptosis in H4IIE Hepatocellular Carcinoma Cells. Dev Reprod. 2024 Dec;28(4):163-174. PMID: 39845516", "BibTeX": "@article{39845516, title={Fatty Acid Synthase (FASN) Inhibitors Suppress Metformin-Induced Fat Accumulation and Apoptosis in H4IIE Hepatocellular Carcinoma Cells.}, author={Park D and Boo H}, journal={Dev Reprod}, volume={28}, number={4}, pages={163-174}}"}}, {"_id": "35684088", "pmid": 35684088, "pmcid": "PMC9182976", "title": "Metformin Prevents Key Mechanisms of Obesity-Related Complications in Visceral White Adipose Tissue of Obese Pregnant Mice", "journal": "Nutrients", "authors": ["Schmitz K", "Turnwald EM", "Kretschmer T", "Janoschek R", "Bae-Gartz I", "Voßbrecher K", "Kammerer MD", "Köninger A", "Gellhaus A", "Handwerk M", "Wohlfarth M", "Gründemann D", "Hucklenbruch-Rother E", "Dötsch J", "Appel S"], "date": "2022-05-30T00:00:00Z", "doi": "10.3390/nu14112288", "meta_date_publication": "2022 May 30", "meta_volume": "14", "meta_issue": "11", "meta_pages": "", "score": 50255.633, "text_hl": "On gestational day G15.5, phenotypic data were collected and perigonadal WAT (pgWAT) morphology and proteome were examined. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment reduced @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ and @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@visceral fat accumulation@@@. ", "citations": {"NLM": "Schmitz K, Turnwald EM, Kretschmer T, Janoschek R, Bae-Gartz I, Voßbrecher K, Kammerer MD, Köninger A, Gellhaus A, Handwerk M, Wohlfarth M, Gründemann D, Hucklenbruch-Rother E, Dötsch J, Appel S. Metformin Prevents Key Mechanisms of Obesity-Related Complications in Visceral White Adipose Tissue of Obese Pregnant Mice Nutrients. 2022 May 30;14(11):. PMID: 35684088", "BibTeX": "@article{35684088, title={Metformin Prevents Key Mechanisms of Obesity-Related Complications in Visceral White Adipose Tissue of Obese Pregnant Mice}, author={Schmitz K and Turnwald EM and Kretschmer T and Janoschek R and Bae-Gartz I and Voßbrecher K and Kammerer MD and Köninger A and Gellhaus A and Handwerk M and Wohlfarth M and Gründemann D and Hucklenbruch-Rother E and Dötsch J and Appel S}, journal={Nutrients}, volume={14}, number={11}}"}}, {"_id": "38075252", "pmid": 38075252, "pmcid": "PMC10704432", "title": "Metformin-loaded PLGA microspheres combined with an in situ-formed injectable SA/BG hydrogel alleviate rotator cuff muscle degeneration", "journal": "Mater Today Bio", "authors": ["Wang Y", "Song W", "Li Y", "Zhou Z", "Li C", "Yu W", "He Y"], "date": "2023-11-23T00:00:00Z", "doi": "10.1016/j.mtbio.2023.100874", "meta_date_publication": "2023 Dec", "meta_volume": "23", "meta_issue": "", "meta_pages": "100874", "score": 50253.734, "text_hl": "In this study, an in situ-formed injectable @CHEMICAL_Alginates @CHEMICAL_MESH:D000464 @@@sodium alginate@@@ (@CHEMICAL_Alginates @CHEMICAL_MESH:D000464 @@@SA@@@) and bioglass (BG) hydrogel consisting of @CHEMICAL_Polylactic_Acid_Polyglycolic_Acid_Copolymer @CHEMICAL_MESH:D000077182 @@@poly (lactic-co-glycolic acid)@@@ (@CHEMICAL_Polylactic_Acid_Polyglycolic_Acid_Copolymer @CHEMICAL_MESH:D000077182 @@@PLGA@@@) microspheres containing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@CHEMICAL_Alginates @CHEMICAL_MESH:D000464 @@@SA@@@/BG-PLGA-Met) was developed for the prevention of muscular @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@fat@@@ infiltration and @DISEASE_Retinal_Dystrophies @DISEASE_MESH:D058499 @@@dystrophy@@@. ", "citations": {"NLM": "Wang Y, Song W, Li Y, Zhou Z, Li C, Yu W, He Y. Metformin-loaded PLGA microspheres combined with an in situ-formed injectable SA/BG hydrogel alleviate rotator cuff muscle degeneration Mater Today Bio. 2023 Dec;23():100874. PMID: 38075252", "BibTeX": "@article{38075252, title={Metformin-loaded PLGA microspheres combined with an in situ-formed injectable SA/BG hydrogel alleviate rotator cuff muscle degeneration}, author={Wang Y and Song W and Li Y and Zhou Z and Li C and Yu W and He Y}, journal={Mater Today Bio}, volume={23}, pages={100874}}"}}, {"_id": "35594738", "pmid": 35594738, "title": "Moderate exercise combined with metformin-treatment improves mitochondrial bioenergetics of the quadriceps muscle of old female Wistar rats.", "journal": "Arch Gerontol Geriatr", "authors": ["López-Cervantes SP", "Sánchez NS", "Calahorra M", "Mena-Montes B", "Pedraza-Vázquez G", "Hernández-Álvarez D", "Esparza-Perusquía M", "Peña A", "López-Díazguerrero NE", "Alarcón-Aguilar A", "Luna-López A", "Flores-Herrera Ó", "Königsberg M"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.archger.2022.104717", "meta_date_publication": "2022 Sep-Oct", "meta_volume": "102", "meta_issue": "", "meta_pages": "104717", "score": 50249.875, "text_hl": "Our research group has shown that the combined treatment of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MTF@@@) and exercise has beneficial effects for preventing @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@muscle loss@@@ and @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@fat accumulation@@@, by modulating the redox state. ", "citations": {"NLM": "López-Cervantes SP, Sánchez NS, Calahorra M, Mena-Montes B, Pedraza-Vázquez G, Hernández-Álvarez D, Esparza-Perusquía M, Peña A, López-Díazguerrero NE, Alarcón-Aguilar A, Luna-López A, Flores-Herrera Ó, Königsberg M. Moderate exercise combined with metformin-treatment improves mitochondrial bioenergetics of the quadriceps muscle of old female Wistar rats. Arch Gerontol Geriatr. 2022 Sep-Oct;102():104717. PMID: 35594738", "BibTeX": "@article{35594738, title={Moderate exercise combined with metformin-treatment improves mitochondrial bioenergetics of the quadriceps muscle of old female Wistar rats.}, author={López-Cervantes SP and Sánchez NS and Calahorra M and Mena-Montes B and Pedraza-Vázquez G and Hernández-Álvarez D and Esparza-Perusquía M and Peña A and López-Díazguerrero NE and Alarcón-Aguilar A and Luna-López A and Flores-Herrera Ó and Königsberg M}, journal={Arch Gerontol Geriatr}, volume={102}, pages={104717}}"}}, {"_id": "37100305", "pmid": 37100305, "title": "Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice.", "journal": "J Nutr Biochem", "authors": ["Goodarzi G", "Tehrani SS", "Panahi G", "Bahramzadeh A", "Meshkani R"], "date": "2023-08-01T00:00:00Z", "doi": "10.1016/j.jnutbio.2023.109369", "meta_date_publication": "2023 Aug", "meta_volume": "118", "meta_issue": "", "meta_pages": "109369", "score": 50245.777, "text_hl": "Our results showed that the combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ and @CHEMICAL_p_coumaric_acid @CHEMICAL_MESH:C495469 @@@PCA@@@ markedly ameliorated @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ and @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@fat deposition@@@ in HFD fed @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Goodarzi G, Tehrani SS, Panahi G, Bahramzadeh A, Meshkani R. Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice. J Nutr Biochem. 2023 Aug;118():109369. PMID: 37100305", "BibTeX": "@article{37100305, title={Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice.}, author={Goodarzi G and Tehrani SS and Panahi G and Bahramzadeh A and Meshkani R}, journal={J Nutr Biochem}, volume={118}, pages={109369}}"}}, {"_id": "34481828", "pmid": 34481828, "title": "Neonatal metformin short exposure inhibits male reproductive dysfunction caused by a high-fat diet in adult rats.", "journal": "Toxicol Appl Pharmacol", "authors": ["Vieira HR", "Gonçalves GD", "Alves VS", "de Melo MAB", "Borges SC", "Klagenberg J", "Neves CQ", "Previate C", "Saavedra LPJ", "Siervo GEML", "Malta A", "Prado MAAC", "Palma-Rigo K", "Buttow NC", "Fernandes GSA", "Mathias PCF"], "date": "2021-10-15T00:00:00Z", "doi": "10.1016/j.taap.2021.115712", "meta_date_publication": "2021 Oct 15", "meta_volume": "429", "meta_issue": "", "meta_pages": "115712", "score": 50245.453, "text_hl": "Early @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ exposure positively affected the male reproductive system of adult @SPECIES_10116 @@@rats@@@, preventing reproductive @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@HF disorders@@@. ", "citations": {"NLM": "Vieira HR, Gonçalves GD, Alves VS, de Melo MAB, Borges SC, Klagenberg J, Neves CQ, Previate C, Saavedra LPJ, Siervo GEML, Malta A, Prado MAAC, Palma-Rigo K, Buttow NC, Fernandes GSA, Mathias PCF. Neonatal metformin short exposure inhibits male reproductive dysfunction caused by a high-fat diet in adult rats. Toxicol Appl Pharmacol. 2021 Oct 15;429():115712. PMID: 34481828", "BibTeX": "@article{34481828, title={Neonatal metformin short exposure inhibits male reproductive dysfunction caused by a high-fat diet in adult rats.}, author={Vieira HR and Gonçalves GD and Alves VS and de Melo MAB and Borges SC and Klagenberg J and Neves CQ and Previate C and Saavedra LPJ and Siervo GEML and Malta A and Prado MAAC and Palma-Rigo K and Buttow NC and Fernandes GSA and Mathias PCF}, journal={Toxicol Appl Pharmacol}, volume={429}, pages={115712}}"}}, {"_id": "36196729", "pmid": 36196729, "title": "Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with Type 2 diabetes mellitus.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Keskin L", "Yaprak B"], "date": "2022-09-01T00:00:00Z", "doi": "10.26355/eurrev_202209_29783", "meta_date_publication": "2022 Sep", "meta_volume": "26", "meta_issue": "18", "meta_pages": "6813-6820", "score": 50239.55, "text_hl": "CONCLUSIONS: The effect of the combination of liraglutide 3 mg and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ regulation, @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ (@<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@fat loss@@@, muscle conservation) was found to be superior to the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy in the @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 diabetes mellitus@@@ according to the early period results.", "citations": {"NLM": "Keskin L, Yaprak B. Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with Type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2022 Sep;26(18):6813-6820. PMID: 36196729", "BibTeX": "@article{36196729, title={Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with Type 2 diabetes mellitus.}, author={Keskin L and Yaprak B}, journal={Eur Rev Med Pharmacol Sci}, volume={26}, number={18}, pages={6813-6820}}"}}, {"_id": "31730174", "pmid": 31730174, "title": "Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments.", "journal": "J Clin Endocrinol Metab", "authors": ["Díaz M", "Bassols J", "López-Bermejo A", "de Zegher F", "Ibáñez L"], "date": "2020-03-01T00:00:00Z", "doi": "10.1210/clinem/dgz204", "meta_date_publication": "2020 Mar 1", "meta_volume": "105", "meta_issue": "3", "meta_pages": "", "score": 50236.42, "text_hl": "OBJECTIVE: We studied the baseline microRNA (miRNA) profile of girls with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, and the effects of a randomized treatment with an oral contraceptive (OC) or with @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@-@CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (SPIOMET, aiming at loss of hepato-visceral @<m>DISEASE_Embolism_Fat</m> @DISEASE_MESH:D004620 @@@fat@@@ excess) for 1 year. ", "citations": {"NLM": "Díaz M, Bassols J, López-Bermejo A, de Zegher F, Ibáñez L. Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments. J Clin Endocrinol Metab. 2020 Mar 1;105(3):. PMID: 31730174", "BibTeX": "@article{31730174, title={Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments.}, author={Díaz M and Bassols J and López-Bermejo A and de Zegher F and Ibáñez L}, journal={J Clin Endocrinol Metab}, volume={105}, number={3}}"}}]}